Efficacy and safety of first-line therapies for persistent, recurrent, or metastatic cervical cancer: a systematic review and exploratory network meta-analysis of immunotherapy
BackgroundThe first-line treatment for persistent, recurrent, or metastatic cervical cancer continues to pose significant clinical challenges. While the application of immune checkpoint inhibitors (ICIs) has transformed the existing treatment paradigm,…